4b1d
From Proteopedia
(Difference between revisions)
m (Protected "4b1d" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | + | [[Image:4b1d.jpg|left|200px]] | |
| - | + | {{STRUCTURE_4b1d| PDB=4b1d | SCENE= }} | |
| - | + | ===New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain=== | |
| - | + | {{ABSTRACT_PUBMED_23017051}} | |
| + | |||
| + | ==About this Structure== | ||
| + | [[4b1d]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4B1D OCA]. | ||
| + | [[Category: Memapsin 2]] | ||
| + | [[Category: Berg, S.]] | ||
| + | [[Category: Blid, J.]] | ||
| + | [[Category: Eketjall, S.]] | ||
| + | [[Category: Falting, J.]] | ||
| + | [[Category: Ginman, T.]] | ||
| + | [[Category: Gravenfors, Y.]] | ||
| + | [[Category: Janson, J.]] | ||
| + | [[Category: Jeppsson, F.]] | ||
| + | [[Category: Johansson, P.]] | ||
| + | [[Category: Karlstrom, S.]] | ||
| + | [[Category: Kieseritzky, F.]] | ||
| + | [[Category: Kihlstrom, J.]] | ||
| + | [[Category: Kolmodin, K.]] | ||
| + | [[Category: Lindstrom, J.]] | ||
| + | [[Category: Olsson, L.]] | ||
| + | [[Category: Rahm, F.]] | ||
| + | [[Category: Slivo, C.]] | ||
| + | [[Category: Stromberg, K.]] | ||
| + | [[Category: Swahn, B.]] | ||
| + | [[Category: Viklund, J.]] | ||
| + | [[Category: Hydrolase]] | ||
| + | [[Category: Inhibitor]] | ||
| + | [[Category: Lead generation]] | ||
| + | [[Category: Structure-based drug design]] | ||
Revision as of 07:16, 10 October 2012
New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain
Template:ABSTRACT PUBMED 23017051
About this Structure
4b1d is a 1 chain structure. Full crystallographic information is available from OCA.
Categories: Memapsin 2 | Berg, S. | Blid, J. | Eketjall, S. | Falting, J. | Ginman, T. | Gravenfors, Y. | Janson, J. | Jeppsson, F. | Johansson, P. | Karlstrom, S. | Kieseritzky, F. | Kihlstrom, J. | Kolmodin, K. | Lindstrom, J. | Olsson, L. | Rahm, F. | Slivo, C. | Stromberg, K. | Swahn, B. | Viklund, J. | Hydrolase | Inhibitor | Lead generation | Structure-based drug design
